Share
Market Research Report

CAR T-CELL THERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Targeted AntigenCD19 · BCMA · HER2 · GD2 · CD20 · CD22 · CD30 · CD33 · HER1 · and Others
  • By Therapeutic ApplicationHematological Malignancies and Solid Tumors
  • By Therapy TypeAutologous CAR T-cell Therapy and Allogeneic CAR T-cell Therapy
  • By End UserHospitals · Cancer Treatment Centers · Academic and Research Institutes · and Others
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In24 Apr 2026
  • Report CodeCMI102
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global CAR T-cell Therapy Market, By Targeted Antigen
      • Global CAR T-cell Therapy Market, By Therapeutic Application
      • Global CAR T-cell Therapy Market, By Therapy Type
      • Global CAR T-cell Therapy Market, By End User
      • Global CAR T-cell Therapy Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trends
  4. Global CAR T-cell Therapy Market, By Targeted Antigen, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • CD19
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • BCMA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • HER2
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • GD2
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • CD20
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • CD22
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • CD30
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • CD33
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • HER1
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  5. Global CAR T-cell Therapy Market, By Therapeutic Application, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hematological Malignancies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Solid Tumors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  6. Global CAR T-cell Therapy Market, By Therapy Type, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Autologous CAR T-cell Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Allogeneic CAR T-cell Therapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  7. Global CAR T-cell Therapy Market, By End User, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Cancer Treatment Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Academic and Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  8. Global CAR T-cell Therapy Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Targeted Antigen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Targeted Antigen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Targeted Antigen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Targeted Antigen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Targeted Antigen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Targeted Antigen, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  9. Competitive Landscape

    • Bristol-Myers Squibb Company
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Johnson & Johnson Services, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Gilead Sciences, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Legend Biotech
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • bluebird bio, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CARsgen Therapeutics Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Mustang Bio
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Fate Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sorrento Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  10. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  11. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on 'CAR T-cell Therapy Market' - Global forecast to 2033